plastic Posted September 12, 2011 Share Posted September 12, 2011 Looks more like another PGL to me. Similar sort of events too. Alleged insider trading with protagonists not being prosecuted or even investigated coupled with naked shorting on the back of a "surprise" decision which is supposedly contra to PXS progressing its lead drug. I expect the outcome will be the same as PGL as well. I wouldn't be going near this thing with a barge pole. Hope I am wrong. Link to comment Share on other sites More sharing options...
krisbarry1 Posted September 28, 2011 Share Posted September 28, 2011 TESTING 1,2,4 opps Link to comment Share on other sites More sharing options...
JMH03 Posted October 21, 2011 Share Posted October 21, 2011 PXS receives positive approval from the EU. Requests further study for children and adolescents, however don't forget physicans will likely perscribe bronchitol off label to this patient group all the same! fantastic news!! im predicting $1.70-$2 on Monday. What a ride it has been...but importantly great news for CF sufferers Link to comment Share on other sites More sharing options...
macduffy Posted February 1, 2012 Share Posted February 1, 2012 "Pharmaxis upside unappreciated" ? http://www.fnarena.com/index2.cfm?type=dsp...F151E7F4F471232 Link to comment Share on other sites More sharing options...
plastic Posted February 8, 2012 Share Posted February 8, 2012 How come there was no mention of the inside trading and naked short when they got that knock back? Wouldn't touch this in a million years. Not even the authorities want to investigate what is blatant illegality. Which means those who aren't on the inside haven't got a chance. We need a precedent like below and the first place they should look is PXS and Citigroup. Same thing happened with the insider trading probe on PGL and eG Capital. Sooner or later it all got swept under the carpet after the perfunctory lip service and now look at PGL. Washington, D.C., Jan. 31, 2012 ÃÆâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¡Ãƒâہ¡ÃƒÆ’‚¬ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒâ€¦Ã‚¡ÃƒÆ’‚¬Ãƒâ€Â¦ÃƒÆ’¢Ã¢Ã¢â‚¬Å¡Ã‚¬Ãƒâ€¦Ã¢â‚¬Å“ The Securities and Exchange Commission today charged two brothers living in Chicago and New York with naked short selling for failing to locate and deliver shares involved in short sales to broker-dealers. Short sellers sell borrowed shares in hopes of profiting from declining prices. While short selling is legal, SEC rules require short sellers to locate shares to borrow before selling them short, and they must deliver the borrowed securities by a specified date. Market makers are excepted from the locate requirement when selling short in connection with bona-fide market making activities in the security for which the exception is claimed. Naked short selling occurs without having borrowed the securities to make delivery. According to the SECÃÆâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¡Ãƒâہ¡ÃƒÆ’‚¬ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¾Ãƒâہ¡ÃƒÆ’‚¢s order instituting administrative proceedings against Jeffrey A. Wolfson and Robert A. Wolfson, they generated more than $17 million in ill-gotten gains from naked short selling transactions involving such stocks as Chipotle Mexican Grill Inc., Fairfax Financial Holdings Ltd., Novastar Financial Inc., and NYSE Group. As Jeffrey Wolfson stated in a recorded telephone conversation, ÃÆâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¡Ãƒâہ¡ÃƒÆ’‚¬ÃƒÆ’â€Â¦ÃƒƒÂ¢Ãƒ¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…âہ“What I sell them is not guaranteed, it never gets delivered, itÃÆâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¡Ãƒâہ¡ÃƒÆ’‚¬ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¾Ãƒâہ¡ÃƒÆ’‚¢s funny paper.ÃÆâ€â„¢ÃƒÆ’ƒâہ¡ÃƒÆ’‚¢ÃƒÆ’¢Ã¢Ã¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¡Ãƒâہ¡ÃƒÆ’‚¬ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚ Link to comment Share on other sites More sharing options...
plastic Posted April 10, 2012 Share Posted April 10, 2012 Has there been any progress on the inside trading case that was supposed to be mounted against the CEO? Link to comment Share on other sites More sharing options...
floyd Posted April 10, 2012 Share Posted April 10, 2012 ok plastic fantastic ill bite... what insider trading case has been brought against the ceo? i hope this is real and not some illusion you've dreamt up again Link to comment Share on other sites More sharing options...
plastic Posted April 10, 2012 Share Posted April 10, 2012 I recall somebody saying an investigation was going to be launched since he sold his shares just before they announced Bronchitol had received a negative vote from the EU authorities. I doubt that one will ever happen but it is enough to turn me off this stock. http://www.asx.com.au/asxpdf/20110525/pdf/41yv3wnj6r5gd0.pdf Link to comment Share on other sites More sharing options...
plastic Posted April 10, 2012 Share Posted April 10, 2012 Is why I wouldn't touch PAB either. There are certain companies with certain people kicking around in them whose track record is so appallingly bad that it doesn't matter what argument one puts up or how right it is, it is enough to know the people alone merits a thumbs down on the stock. Link to comment Share on other sites More sharing options...
dr_dazmo Posted July 17, 2012 Share Posted July 17, 2012 Hi All, I don't hold, but was reading the PXS shareholder update today. It all looks very positive (but when is a shareholder update not positive?). I see sales for the 3 months to 30th June are up an impressive 60% on the same period last year, but then COGS are up an even more impressive 142%, reducing the percentage gross margin from 72% to 58%. The 12 months to 30th June is less pronounced sales +46%, COGS +53%. Is there a simple reason for the increase in COGS in the 3 months to 30/6/12? Cheers Dr_Dazmo Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now